Reuters: Roche says sugar technology has anticancer promise

[NaDiNe]

Roche says sugar technology has anticancer promise
      

NEW YORK (Reuters) - Swiss drugmaker Roche Holding AG on Tuesday said results from a preclinical study suggest that sugar related technology acquired through its purchase of GlycArt Biotechnology AG may boost effectiveness of cancer drugs.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login